Delcath Systems price to sales ratio DCTH

Market value divided by revenue over the last twelve months, since 2018.

Today, Oct 23, 2026: 5.2×
8-year median: 10.1×
Against its 8-year history: 34th; percentile: 0 is its lowest day, 100 its highest
8-year range: 0.0× to 67.9×
Peer median: 2.0×

Delcath Systems' price to sales ratio is 5.2× as of Oct 23, 2026.

That is below its 8-year median of 10.1×, lower than on 66% of days in the last 8 years.

Over that time it ranged from 0.0× in Nov 2018 to 67.9× in May 2024.

The median for 10 medical instruments and supplies stocks of a similar size is 2.0×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	5.2×	3.6×	6.2×
2025	4.6×	3.8×	23.0×
2024	16.9×	13.3×	67.9×
2023	42.4×	7.2×	42.4×
2022	7.4×	5.8×	28.2×
2021	29.2×	29.2×	53.8×
2020	44.5×	0.1×	44.5×
2019	0.4×	0.0×	0.5×
2018	0.0×	0.0×	0.0×

Against its peers

Companies in Medical - Instruments & Supplies nearest Delcath Systems' size, closest first, today.

Company	Price to sales ratio
DCTHDelcath Systems	5.2×
TCMDTactile Systems Technology	1.5×
MDXGMimedx	1.6×
EMBCEmbecta	0.4×
MOVMovado	1.0×
INFUInfuSystem	1.9×
UTMDUtah Medical Products	6.5×
IRMDIradimed	12.7×
STAAStaar Surgical	3.3×
PDEXPro DEX	2.6×
BVSBioventus	2.2×
Peer median	2.0×

Where Delcath Systems ranks

#89of 116Medical instruments and supplies stocks with the lowest price to sales ratio

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Delcath Systems

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.